GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (OSTO:ONCOZ) » Definitions » Common Stock

OncoZenge AB (OSTO:ONCOZ) Common Stock : kr1.30 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB Common Stock?

OncoZenge AB's quarterly common stock stayed the same from Jun. 2024 (kr1.30 Mil) to Sep. 2024 (kr1.30 Mil) and stayed the same from Sep. 2024 (kr1.30 Mil) to Dec. 2024 (kr1.30 Mil).

OncoZenge AB's annual common stock stayed the same from Dec. 2022 (kr1.30 Mil) to Dec. 2023 (kr1.30 Mil) and stayed the same from Dec. 2023 (kr1.30 Mil) to Dec. 2024 (kr1.30 Mil).

OncoZenge AB Common Stock Historical Data

The historical data trend for OncoZenge AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoZenge AB Common Stock Chart

OncoZenge AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
0.50 1.30 1.30 1.30 1.30

OncoZenge AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 1.30 1.30 1.30 1.30

OncoZenge AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

OncoZenge AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (OSTO:ONCOZ) » Definitions » Common Stock
Comparable Companies
XSAT:DEX OSTO:SIMRIS B OSTO:SPAGO OSTO:BIOSGN XSAT:NIDHOG OSTO:ACOU OSTO:PILA OSTO:EXPRS2 XSAT:ABERA XSAT:CHOSA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
8LY:Germany
Address
Gustavslundsvagen 34, Bromma, SWE, 167 51
Website
https://www.oncozenge.com
OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.

OncoZenge AB Headlines

No Headlines